The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

PHASE3CompletedINTERVENTIONAL
Enrollment

530

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Migraine Disorders
Interventions
DRUG

NP101 - Sumatriptan iontophoretic transdermal patch

Sumatriptan iontophoretic transdermal patch

DRUG

Placebo

NP101 Placebo iontophoretic transdermal patch

Trial Locations (34)

Unknown

Phoenix

Little Rock

Newport Beach

San Francisco

Santa Monica

Fairfield

Ocala

Palm Beach Gardens

Sunrise

Atlanta

Columbus

Decatur

Savannah

Chicago

Ann Arbor

Kalamazoo

Springfield

St Louis

Mount Vernon

Plainview

Greensboro

West Chester

Oklahoma City

Philadelphia

Pittsburgh

Wynnewood

Memphis

Nashville

Dallas

Houston

San Antonio

Alexandria

Virginia Beach

Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

NuPathe Inc.

INDUSTRY